Aroa Biosurgery (ASX:ARX) Change In Inventory : A$0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Change In Inventory?

Aroa Biosurgery's change in inventory for the quarter that ended in Mar. 2024 was A$0.00 Mil. It means Aroa Biosurgery's inventory stayed the same from Sep. 2023 to Mar. 2024 .

Aroa Biosurgery's change in inventory for the fiscal year that ended in Mar. 2024 was A$0.00 Mil. It means Aroa Biosurgery's inventory stayed the same from Mar. 2023 to Mar. 2024 .

Aroa Biosurgery's Total Inventories for the quarter that ended in Mar. 2024 was A$7.43 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Aroa Biosurgery's Days Inventory for the quarter that ended in Mar. 2024 was 278.60.

Inventory Turnover measures how fast the company turns over its inventory within a year. Aroa Biosurgery's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.66.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Aroa Biosurgery's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.20.

Aroa Biosurgery Change In Inventory Historical Data

The historical data trend for Aroa Biosurgery's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Change In Inventory Chart

Aroa Biosurgery Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Inventory

Aroa Biosurgery Semi-Annual Data
	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Change In Inventory	Get a 7-Day Free Trial			-	-	-	-	-

Aroa Biosurgery Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Aroa Biosurgery (ASX:ARX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Aroa Biosurgery's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	6.952	/	4.554	*	365 / 2
	=	278.60

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Aroa Biosurgery's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	4.554	/	6.952
	=	0.66

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Aroa Biosurgery's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	6.952	/	34.382
	=	0.20

Aroa Biosurgery Change In Inventory Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Aroa Biosurgery (ASX:ARX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022

Website

https://www.aroabio.com

Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines